cyclohexanol has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giridharagopalan, S; Hamamoto, DT; Simone, DA | 1 |
| Aghil, O; Bibby, MC; Carrington, SJ; Double, J; Douglas, KT; Phillips, RM; Shing, TK | 1 |
2 other study(ies) available for cyclohexanol and EHS Tumor
| Article | Year |
|---|---|
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
Topics: Animals; Apomorphine; Benzoxazines; Cannabinoid Receptor Agonists; Catalepsy; Cyclohexanes; Cyclohexanols; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Morpholines; Naphthalenes; Phenols; Receptors, Cannabinoid; Sarcoma, Experimental | 2007 |
Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enone.
Topics: Animals; Antibiotics, Antineoplastic; Cyclohexanols; Cyclohexanones; Drug Screening Assays, Antitumor; Humans; Lactoylglutathione Lyase; Male; Mice; Molecular Structure; Rats; Sarcoma, Experimental; Shikimic Acid; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |